AROLDI, ANDREA
AROLDI, ANDREA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis
2025 Malighetti, F; Villa, M; Villa, A; Pelucchi, S; Aroldi, A; Cortinovis, D; Canova, S; Capici, S; Cazzaniga, M; Mologni, L; Ramazzotti, D; Cordani, N
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies
2024 Malighetti, F; Villa, M; Mauri, M; Piane, S; Crippa, V; Crespiatico, I; Cocito, F; Bossi, E; Steidl, C; Civettini, I; Scollo, C; Ramazzotti, D; Gambacorti-Passerini, C; Piazza, R; Mologni, L; Aroldi, A
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making
2024 Civettini, I; Zappaterra, A; Granelli, B; Rindone, G; Aroldi, A; Bonfanti, S; Colombo, F; Fedele, M; Grillo, G; Parma, M; Perfetti, P; Terruzzi, E; Gambacorti-Passerini, C; Ramazzotti, D; Cavalca, F
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis
2024 Fontana, D; Crespiatico, I; Zaghi, M; Mastini, C; D’Aliberti, D; Mauri, M; Mercado, C; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti-Passerini, C; Elli, E; Mologni, L; Piazza, R
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype
2024 Civettini, I; Zappaterra, A; Corti, P; Messina, A; Aroldi, A; Biondi, A; Cavalca, F; Crippa, V; Crosti, F; Ferrari, G; Malighetti, F; Mologni, L; Piperno, A; Ramazzotti, D; Scollo, C; Zambon, A; Rossi, F; Gambacorti-Passerini, C
Idiopathic erythrocytosis: a germline disease?
2024 Elli, E; Mauri, M; D’Aliberti, D; Crespiatico, I; Fontana, D; Redaelli, S; Pelucchi, S; Spinelli, S; Manghisi, B; Cavalca, F; Aroldi, A; Ripamonti, A; Ferrari, S; Palamini, S; Mottadelli, F; Massimino, L; Ramazzotti, D; Cazzaniga, G; Piperno, A; Gambacorti-Passerini, C; Piazza, R
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas
2023 Rindone, G; Aroldi, A; Bossi, E; Verga, L; Zambrotta, G; Tarantino, S; Piazza, R; Mussolin, L; Chiarle, R; Gambacorti-Passerini, C
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells
2023 Bergaggio, E; Tai, W; Aroldi, A; Mecca, C; Landoni, E; Nüesch, M; Mota, I; Metovic, J; Molinaro, L; Ma, L; Alvarado, D; Ambrogio, C; Voena, C; Blasco, R; Li, T; Klein, D; Irvine, D; Papotti, M; Savoldo, B; Dotti, G; Chiarle, R
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples
2023 Aroldi, A; Angaroni, F; D’Aliberti, D; Spinelli, S; Crespiatico, I; Crippa, V; Piazza, R; Graudenzi, A; Ramazzotti, D
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia
2023 Aroldi, A; Mauri, M; Ramazzotti, D; Villa, M; Malighetti, F; Crippa, V; Cocito, F; Borella, C; Bossi, E; Steidl, C; Scollo, C; Voena, C; Chiarle, R; Mologni, L; Piazza, R; Gambacorti Passerini, C
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients
2023 Fontana, D; Crespiatico, I; Crippa, V; Malighetti, F; Villa, M; Angaroni, F; De Sano, L; Aroldi, A; Antoniotti, M; Caravagna, G; Piazza, R; Graudenzi, A; Mologni, L; Ramazzotti, D
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis
2023 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Lavoro, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti-Passerini, C; Elli, E; Mologni, L; Piazza, R
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors
2022 Boccalatte, F; Mina, R; Aroldi, A; Leone, S; Suryadevara, C; Placantonakis, D; Bruno, B
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia
2022 Gambacorti-Passerini, C; Nicolini, F; Larson, R; Aroldi, A; Fontana, D; Piazza, R; le Coutre, P; Antolini, L; Assouline, S
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706)
2022 Bossi, E; Aroldi, A; Borin, L; Verga, L; Fontana, D; Cocito, F; Manghisi, B; Rindone, G; Cavalca, F; Ripamonti, A; Raggi, M; Malandrin, S; Cavallero, A; Antolini, L; Bonardi, D; Piazza, R; Gambacorti-Passerini, C
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options
2022 Clerico, M; Dogliotti, I; Aroldi, A; Consoli, C; Giaccone, L; Bruno, B; Cavallo, F
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success
2022 Inzoli, E; Aroldi, A; Piazza, R; Gambacorti Passerini, C
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience
2022 Steidl, C; Aroldi, A; Mologni, L; Crespiatico, I; Fontana, D; Mastini, C; Fumagalli, M; Perfetti, P; Borin, L; Valentini, C; Piazza, R; Gambacorti-Passerini, C
Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019
2021 Aroldi, A; Chiarle, R; Gambacorti Passerini, C